- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
Bispecifics and Multivalent Antibodies
13 - 14 June 2012
|
50% Discounts for Academics & SMEs for presenting a poster
Present a poster
In recognition of the significant educational impact and value poster presentations provide our attendees, the Empowered Antibodies Congress would like to provide you with the opportunity to present your latest research and technology.
DEADLINE EXTENDED: SUBMIT YOUR POSTER by Friday 18 May 2012
How to participate
To apply please send your abstract of 200 words or less, written in English, listing the principle author and all contact details to susanna.benaim@informa.com
- Posters submitted by academics, biopharmaceutical and pharmaceutical organisations will not be charged a fee
- Posters submitted by service providers/vendors are welcome and will be subject to evaluation by the scientific advisory board
- Upon approval a fee of £399 + VAT will apply
- Posters will be 1m x 1.5m portrait and held in the exhibition
PART OF OUR EMPOWERED ANTIBODIES CONGRESS 2012
Over 20 industry case studies from Micromet, Merrimack, Genentech, Pfizer, F-Star, Merus, Trion Pharma and more
Over 20 industry case studies from Micromet, Merrimack, Genentech, Pfizer, F-Star, Merus, Trion Pharma and more
Dr Benno Rattel
VP, Nonclinical Development
Micromet
|
Dr Birgit Schoeberl
VP, Discovery
Merrimack
|
Dr Lioudmila Tchistiakova
Senior Director, Global Biotherapeutic Tech.
Pfizer
|
Dr Horst Lindhofer
CEO
Trion Pharma
|
We are extremely proud to present our BEST EVER SPEAKER LINE UP
Do not miss hearing from...........
- Dr Renno Battel, VP, Non-Clincial Development, Micromet, Germany
- Dr John de Kruif, CSO, Merus, The Netherlands
- Dr Greg Elson, Department Head, Manufacturing, NovImmune SA, Switzerland
- Dr Alexander Ibraghimov, Principal Scientist, Biologics, Abbott, USA
- Dr Susan E Lacy, Associate Director, Biologics, Global Pharmaceutical R&D, Abbott, USA
- Dr Markus Thomas, Senior Scientist, Discovery Oncology, Roche Diagnostics, Germany
and many more to come
Feeds | Like | Share    | Calendar |
With over 200 participants, join our linked in group for Empowered Antibodies and start networking before the event and pose your questions to the experts!
Poll
What disease applications are you developing multispecific antibodies for?
Please select an answer
NEW SPEAKER ANNOUNCEMENT
Informa are delighted to welcome Dr Matthias Peipp, Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Germany, presenting on the topic of
Bifunctional fusion proteins mimicking an induced self phenotype promote antitumoral natural killer cell cytotoxicity
To find out more about this presentation, click on the 'prorgramme/abstract updates' tab above